HCAT
NASDAQHealth Catalyst Inc
Price$1.93-0.03 (-1.28%)
2026-03-042026-06-05
News · 26 weeks48+10%
2025-12-142026-06-07
Mix2990d
- SEC Filings11(38%)
- Insider9(31%)
- Other4(14%)
- Earnings3(10%)
- Analyst1(3%)
- Leadership1(3%)
Latest news
25 items- PRMed-Metrix Enters Into Definitive Agreement to Acquire Vitalware to Enhance Coding Accuracy and Net Revenue YieldPARSIPPANY, N.J., June 4, 2026 /PRNewswire/ -- Med-Metrix, LLC ("Med-Metrix"), backed by Harvest Partners and A&M Capital Partners, today announced it has entered into a definitive agreement to acquire Vitalware, an industry-leading revenue workflow and analytics software business owned by Health Catalyst (NASDAQ:HCAT). Vitalware's platform and domain expertise will strengthen Med-Metrix's mid-revenue cycle offering, improving charge capture and coding accuracy, which is expected to help drive measurable improvement in net revenue yield for Med-Metrix's clients. The transaction will augment Med-Metrix's technology-enable
- SECHealth Catalyst Inc filed SEC Form 8-K: Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits8-K - Health Catalyst, Inc. (0001636422) (Filer)
- PRHealth Catalyst to Divest Vitalware for $147 Million, Accelerating Strategic TransformationSALT LAKE CITY, June 04, 2026 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. (("Health Catalyst" or the "Company, NASDAQ:HCAT) today announced it has signed a definitive agreement to divest Vitalware, LLC and the Vitalware business unit, its mid-revenue cycle business, to Med-Metrix for a total consideration of $147 million in cash. This divestiture sharpens Health Catalyst's focus on driving measurable improvement for health systems across cost, clinical, and consumer performance, and the Company expects it to accelerate the broader transformation underway. "This is a big step forward for Health Catalyst. We are concentrating our business around the areas where we have the deepest conviction,
- INSIDERCEO Albert Benjamin covered exercise/tax liability with 336 shares, decreasing direct ownership by 0.02% to 1,458,456 units (SEC Form 4) to satisfy withholding obligation4 - Health Catalyst, Inc. (0001636422) (Issuer)
- INSIDERChief People Officer Llewelyn Linda covered exercise/tax liability with 8,519 shares, decreasing direct ownership by 3% to 321,132 units (SEC Form 4) to cover taxes4 - Health Catalyst, Inc. (0001636422) (Issuer)
- INSIDERChief Financial Officer Alger Jason covered exercise/tax liability with 18,804 shares, decreasing direct ownership by 3% to 722,840 units (SEC Form 4) (for withholding tax)4 - Health Catalyst, Inc. (0001636422) (Issuer)
- INSIDERGeneral Counsel Landry Benjamin covered exercise/tax liability with 13,779 shares, decreasing direct ownership by 4% to 364,539 units (SEC Form 4) (tax liability)4 - Health Catalyst, Inc. (0001636422) (Issuer)
- INSIDERDirector Larson-Green Julie was granted 12,710 shares, increasing direct ownership by 16% to 94,644 units (SEC Form 4)4 - Health Catalyst, Inc. (0001636422) (Issuer)
- SECSEC Form DEFA14A filed by Health Catalyst IncDEFA14A - Health Catalyst, Inc. (0001636422) (Filer)
- SECSEC Form DEF 14A filed by Health Catalyst IncDEF 14A - Health Catalyst, Inc. (0001636422) (Filer)
- SECSEC Form PRE 14A filed by Health Catalyst IncPRE 14A - Health Catalyst, Inc. (0001636422) (Filer)
- SECSEC Form 10-Q filed by Health Catalyst Inc10-Q - Health Catalyst, Inc. (0001636422) (Filer)
- SECHealth Catalyst Inc filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits8-K - Health Catalyst, Inc. (0001636422) (Filer)
- PRHealth Catalyst Reports First Quarter 2026 ResultsSALT LAKE CITY, May 11, 2026 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. (("Health Catalyst, NASDAQ:HCAT), a healthcare intelligence company designed to accelerate measurable improvement for health systems, today reported financial results for the quarter ended March 31, 2026. "We delivered solid first quarter results, with revenue and adjusted EBITDA exceeding expectations," said Ben Albert, Chief Executive Officer of Health Catalyst. "More importantly, this quarter we took the first decisive step toward transforming our operating model and aligning the company around its highest-conviction technology opportunities. This is not a short-term cost exercise. It is a strategic reset designed t
- INSIDERDirector Nelson Steven H was granted 154,808 shares (SEC Form 4)4 - Health Catalyst, Inc. (0001636422) (Issuer)
- INSIDERSEC Form 3 filed by new insider Nelson Steven H3 - Health Catalyst, Inc. (0001636422) (Issuer)
- INSIDERCEO Albert Benjamin was granted 1,124 shares and covered exercise/tax liability with 310 shares, increasing direct ownership by 0.06% to 1,458,792 units (SEC Form 4) (for tax liability)4 - Health Catalyst, Inc. (0001636422) (Issuer)
- PRHealth Catalyst to Announce First Quarter 2026 Operating Results and Host Conference Call on Monday, May 11, 2026SALT LAKE CITY, May 01, 2026 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ((", Health Catalyst", , NASDAQ:HCAT), a healthcare intelligence company designed to accelerate measurable improvement for health systems, will release its first quarter 2026 operating results on Monday, May 11, 2026, after market close. In conjunction, the company will host a conference call to review the results at 5:00 pm ET on the same day. Conference Call Details The conference call can be accessed by dialing 800-343-5172 for U.S. participants, or 203-518-9856 for international participants, and referencing conference ID "HCATQ126." A live audio webcast will be available online at https://ir.healthcatalyst.com/.
- SECAmendment: SEC Form 10-K/A filed by Health Catalyst Inc10-K/A - Health Catalyst, Inc. (0001636422) (Filer)
- PRHealth Catalyst Appoints Steve Nelson, President of Aetna, to Its Board of DirectorsSALT LAKE CITY, April 30, 2026 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. (("Health Catalyst", NASDAQ:HCAT), a healthcare intelligence company designed to accelerate measurable improvement for health systems, today announced that Steve Nelson, Executive Vice President and President of Aetna, a CVS Health company, has been appointed to its Board of Directors, effective May 1, 2026. Nelson's appointment follows the naming of Ben Albert as CEO and Justin Spencer as Chairman of the Board earlier this year, continuing a deliberate pattern of leadership moves designed to accelerate the company's transformation– executing on a single, coordinated strategy to help health systems address cost, cli
- SECHealth Catalyst Inc filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits8-K - Health Catalyst, Inc. (0001636422) (Filer)
- SECAmendment: SEC Form SCHEDULE 13G/A filed by Health Catalyst IncSCHEDULE 13G/A - Health Catalyst, Inc. (0001636422) (Subject)
- ANALYSTHealth Catalyst downgraded by Wells Fargo with a new price targetWells Fargo downgraded Health Catalyst from Overweight to Equal Weight and set a new price target of $1.00
- SECAmendment: SEC Form SCHEDULE 13D/A filed by Health Catalyst IncSCHEDULE 13D/A - Health Catalyst, Inc. (0001636422) (Subject)
- INSIDERCEO Albert Benjamin covered exercise/tax liability with 70,455 shares, decreasing direct ownership by 5% to 1,457,978 units (SEC Form 4)4 - Health Catalyst, Inc. (0001636422) (Issuer)
HCAT FAQ
7 questionsWhat does Health Catalyst Inc do?
Health Catalyst, Inc. provides data and analytics technology and services to healthcare organizations. Its solutions include a cloud-based data platform, analytics software, and professional services. The company was formerly known as HQC Holdings, Inc. and changed its name to Health Catalyst, Inc. in March 2017. The company was founded in 2008 and is headquartered in South Jordan, Utah.Where does HCAT stock trade?
Health Catalyst Inc (HCAT) is listed on NASDAQ.What sector and industry is HCAT in?
Health Catalyst Inc operates in the Technology sector, Computer Software: Programming Data Processing industry.When did Health Catalyst Inc go public?
Health Catalyst Inc (HCAT) completed its IPO in 2019.What are analysts saying about HCAT?
Health Catalyst Inc has had 8 recent analyst actions on file. The most recent action was from Wells Fargo: Equal Weight with a $100.00 price target on 2026-03-18.What companies are similar to HCAT?
Notable peers in the same industry include GOOGL (Alphabet Inc.), GOOG (Alphabet Inc.), META (Meta Platforms Inc.), APP (Applovin Corporation), NBIS (Nebius Group N.V.). Compare HCAT side-by-side with any of them on Quantisnow.How can I track HCAT on Quantisnow?
Quantisnow aggregates Health Catalyst Inc's SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow HCAT to receive live email and push alerts on every new disclosure.